nice tirzepatide obesity Rolling out for weight management: NHS England recommendations FDA approval for Zepbound (tirzepatide)

John Roxborough, MD , offers personalized guidance to help you decide between Tirzepatide and Semaglutide

Moderate aerobic activity (150 min/week)

The STEP (Semaglutide Treatment Effect in People with obesity) 1 trial was a randomized, placebo-controlled trial that evaluated the efficacy of once-weekly subcutaneous (SC) semaglutide 2.4 mg plus lifestyle interventions in adults with obesity without diabetes (n = 1961)

Adults with weight-related health concerns may be eligible for compounded tirzepatide , but a licensed provider must first assess your medical background

These medications should be discontinued before a planned pregnancy, as their effects on fetal development are still being studied

You may notice slightly increased appetite, particularly in the evening